Apotex Health Corp.
APTX.TO
TSX
| 06/30/2026 | |||||
|---|---|---|---|---|---|
| Net Income | -110.30% | ||||
| Total Depreciation and Amortization | 31.39% | ||||
| Total Amortization of Deferred Charges | -20.48% | ||||
| Total Other Non-Cash Items | 135.53% | ||||
| Change in Net Operating Assets | -141.32% | ||||
| Cash from Operations | -92.98% | ||||
| Capital Expenditure | -87.94% | ||||
| Sale of Property, Plant, and Equipment | -- | ||||
| Cash Acquisitions | -- | ||||
| Divestitures | -- | ||||
| Other Investing Activities | -58.26% | ||||
| Cash from Investing | -75.36% | ||||
| Total Debt Issued | -- | ||||
| Total Debt Repaid | -1,415.30% | ||||
| Issuance of Common Stock | -- | ||||
| Repurchase of Common Stock | -- | ||||
| Issuance of Preferred Stock | -- | ||||
| Repurchase of Preferred Stock | -- | ||||
| Total Dividends Paid | -- | ||||
| Other Financing Activities | -- | ||||
| Cash from Financing | 505.90% | ||||
| Foreign Exchange rate Adjustments | 164.45% | ||||
| Miscellaneous Cash Flow Adjustments | -- | ||||
| Net Change in Cash | -37.03% | ||||